CQENS Technologies
CQENS Technologies Inc. is a US-based company specializing in invention and development of devices and methods for inhalation that heat, but do not burn, plant-based and medicant-infused substrates to produce aerosols. The company focuses on harm reduction, innovation, and the inventive spirit, with an extensive IP portfolio including 92 US and international patents and pending patents. It maintains operations in Minnesota and California, and is led by a team of experienced inventors, executives, and advisors dedicated to public health and wellness through advanced inhalation technologies.
Industries
Nr. of Employees
small (1-50)
Patents
Products
Prototype non-combustion inhalation device
Prototype devices implementing low-temperature and high-temperature non-combustion heating methods to generate inhalable aerosols; prototypes have undergone independent performance and toxicology evaluations.
Prototype non-combustion inhalation device
Prototype devices implementing low-temperature and high-temperature non-combustion heating methods to generate inhalable aerosols; prototypes have undergone independent performance and toxicology evaluations.
Services
Inventive development and prototyping of heating methods and devices to produce aerosols from plant-based or medicant-infused substrates without combustion.
Creation and management of patentable methods, device designs and formulations with potential licensing opportunities.
Inventive development and prototyping of heating methods and devices to produce aerosols from plant-based or medicant-infused substrates without combustion.
Creation and management of patentable methods, device designs and formulations with potential licensing opportunities.
Expertise Areas
- Inhalation device engineering
- Aerosolization without combustion
- Formulation development for inhalation delivery
- Heat-not-burn (non-combustion) systems
Key Technologies
- Induction heating
- Low-temperature aerosolization
- High-temperature non-combustion aerosolization
- Formulated inhalable substrates
News & Updates
IP Portfolio with 92 US and international patents and pending patents
CQENS has a portfolio that includes 92 US and international patents and pending patents, emphasizing its focus on invention and innovation in inhalation technology.
IP Portfolio with 92 US and international patents and pending patents
CQENS has a portfolio that includes 92 US and international patents and pending patents, emphasizing its focus on invention and innovation in inhalation technology.